SCHEDULE OF SEGMENT INFORMATION (Details) - USD ($) |
3 Months Ended | 6 Months Ended | ||||||
|---|---|---|---|---|---|---|---|---|
Jun. 30, 2026 |
Mar. 31, 2026 |
Jun. 30, 2025 |
Mar. 31, 2025 |
Jun. 30, 2026 |
Jun. 30, 2025 |
|||
| EXPENSES | ||||||||
| General and administrative | $ 2,868,537 | $ 1,394,932 | $ 6,416,390 | $ 3,889,464 | ||||
| Sales and Marketing | 85,715 | 723,937 | ||||||
| Research and development | 5,073 | 17,815 | 10,145 | 50,982 | ||||
| Credit loss expense - short-term note receivable | 271,000 | 142,574 | 468,000 | |||||
| Total expenses | 2,959,325 | 1,683,747 | 7,293,046 | 4,408,446 | ||||
| Total other expense (income), net | 1,228,280 | 1,670 | 2,973,575 | (76,893) | ||||
| NET LOSS | $ 4,187,605 | $ 6,079,016 | $ 1,685,417 | $ 2,646,172 | 10,266,621 | 4,331,588 | ||
| Segment Reporting Expense Information [Member] | ||||||||
| EXPENSES | ||||||||
| General and administrative | 6,416,390 | 3,889,464 | ||||||
| Sales and Marketing | 723,937 | |||||||
| Research and development | 10,145 | 50,982 | ||||||
| Credit loss expense - short-term note receivable | 142,574 | 468,000 | ||||||
| Total expenses | 7,293,046 | 4,408,446 | ||||||
| Total other expense (income), net | [1] | 2,973,575 | (76,858) | |||||
| NET LOSS | $ 10,266,621 | $ 4,331,588 | ||||||
| ||||||||
| X | ||||||||||
- Definition Credit loss expense short term note receivable. No definition available.
|
| X | ||||||||||
- Definition The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business). Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The aggregate total amount of expenses directly related to the marketing or selling of products or services. No definition available.
|
| X | ||||||||||
- Details
|